We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
+9.43%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.02%
AUM
$4.21B
AUM Growth
+$243M
Cap. Flow
+$12.7M
Cap. Flow %
0.3%
Top 10 Hldgs %
8.22%
Holding
1,288
New
116
Increased
426
Reduced
381
Closed
108

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$20.5M
2
NFLX icon
Netflix
NFLX
+$19.9M
3
COST icon
Costco
COST
+$18.6M
4
IBM icon
IBM
IBM
+$17.9M
5
PLTR icon
Palantir
PLTR
+$17.5M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$19.1M
2
QCOM icon
Qualcomm
QCOM
+$19.1M
3
CMCSA icon
Comcast
CMCSA
+$19.1M
4
INTC icon
Intel
INTC
+$19.1M
5
UPS icon
United Parcel Service
UPS
+$19M

Sector Composition

Rank Sector Weight
1 Financials 28.41%
2 Consumer Discretionary 12.52%
3 Industrials 11.69%
4 Technology 11.49%
5 Energy 9.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KPTI icon
1001
Karyopharm Therapeutics
KPTI
$43.3M
$163K ﹤0.01%
+37,836
New +$186K
HHS icon
1002
Harte-Hanks
HHS
$16.8M
$163K ﹤0.01%
40,846
– –
KRMD icon
1003
KORU Medical Systems
KRMD
$190M
$162K ﹤0.01%
45,305
– –
MGNX icon
1004
MacroGenics
MGNX
$248M
$162K ﹤0.01%
133,700
+18,500
+16% +$26.8K
ALEC icon
1005
Alector
ALEC
$165M
$161K ﹤0.01%
+115,000
New +$144K
LYEL icon
1006
Lyell Immunopharma
LYEL
$330M
$159K ﹤0.01%
+18,000
New +$164K
MYO icon
1007
Myomo
MYO
$41M
$159K ﹤0.01%
73,600
– –
PMVP icon
1008
PMV Pharmaceuticals
PMVP
$62.4M
$158K ﹤0.01%
148,800
– –
NTIP icon
1009
Network-1 Technologies
NTIP
$36.6M
$157K ﹤0.01%
128,701
-1,694
-1% -$2.1K
PYXS icon
1010
Pyxis Oncology
PYXS
$198M
$157K ﹤0.01%
142,295
+61,500
+76% +$69.3K
PBHC icon
1011
Pathfinder Bancorp
PBHC
$102M
$156K ﹤0.01%
10,200
– –
USIO icon
1012
Usio Inc
USIO
$64.3M
$155K ﹤0.01%
101,000
– –
AFCG
1013
AFC Gamma
AFCG
$63.4M
$153K ﹤0.01%
34,096
– –
GOCO
1014
DELISTED
GoHealth
GOCO
$150K ﹤0.01%
27,066
+2,058
+8% +$16.3K
CCCC icon
1015
C4 Therapeutics
CCCC
$400M
$150K ﹤0.01%
104,900
-25,000
-19% -$36.4K
BAER icon
1016
Bridger Aerospace
BAER
$103M
$148K ﹤0.01%
76,700
+65,000
+556% +$99.8K
MGX icon
1017
Metagenomi Therapeutics
MGX
$45.9M
$146K ﹤0.01%
98,700
– –
NKTX icon
1018
Nkarta
NKTX
$157M
$146K ﹤0.01%
87,800
– –
SYPR icon
1019
Sypris Solutions
SYPR
$47.9M
$144K ﹤0.01%
65,204
– –
ASRT
1020
DELISTED
Assertio
ASRT
$143K ﹤0.01%
14,893
-2,667
-15% -$25.6K
OPHC icon
1021
OptimumBank Holdings
OPHC
$108M
$141K ﹤0.01%
31,600
– –
AIFC
1022
AI Financial Corp
AIFC
$58.9M
$140K ﹤0.01%
19,339
+1,661
+9% +$11.7K
MCRB icon
1023
Seres Therapeutics
MCRB
$48.4M
$139K ﹤0.01%
12,500
– –
PED icon
1024
PEDEVCO
PED
$133M
$139K ﹤0.01%
10,610
– –
APYX icon
1025
Apyx Medical
APYX
$174M
$139K ﹤0.01%
61,601
-30,000
-33% -$42.2K
39 40
41
42 43

Similar funds

CFC
Cincinnati Financial Corp Fairfield, Ohio $4.96B AUM 18.21% 1-Year Est. Return
SNT
SIG North Trading Bala Cynwyd, Pennsylvania $4.98B AUM 36.24% 1-Year Est. Return
MA
Marshfield Associates Washington, District of Columbia $4.99B AUM 1.59% 1-Year Est. Return
FFB
First Financial Bankshares Abilene, Texas $4.95B AUM 25.06% 1-Year Est. Return
AM
Atreides Management Boston, Massachusetts $5B AUM 78.34% 1-Year Est. Return
SGM
Skye Global Management West Palm Beach, Florida $5B AUM 11.9% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
SMFG
Sumitomo Mitsui Financial Group Tokyo, Japan $4.94B AUM 1.39% 1-Year Est. Return

Bridgeway Capital Management's Q2 2025 Portfolio in Review

As of Q2 2025, Bridgeway Capital Management held 1,288 positions worth $4.21B, up 6.1% from $3.97B the previous quarter. Its ten largest holdings account for 8.2% of the portfolio.

Bridgeway Capital Management's Q2 2025 filing shows 116 new, 426 increased, 381 reduced and 108 closed positions. Its largest new stake was AbbVie: 110,140 shares worth $20.4M. The largest sale was Pfizer, an estimated $19.1M.

By sector, the portfolio is most concentrated in Financials at 28% of assets, down from 29% a quarter earlier, followed by Consumer Discretionary and Industrials.

  • Bridgeway Capital Management's largest Q2 2025 buy was AbbVie: 110,140 shares worth $20.4M.
  • Bridgeway Capital Management added most to Costco in Q2 2025, an estimated $18.6M increase.
  • Bridgeway Capital Management's biggest Q2 2025 reduction was Gulfport Energy Corp, cutting an estimated $14.8M.
  • Bridgeway Capital Management fully exited Pfizer in Q2 2025, selling an estimated $19.1M.
  • Bridgeway Capital Management's ten largest holdings make up 8.2% of its $4.21B portfolio in Q2 2025.
  • Bridgeway Capital Management opened 116 new positions and closed 108 in Q2 2025.
  • Bridgeway Capital Management's portfolio value rose 6.1% quarter-over-quarter to $4.21B.

Based on Bridgeway Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.